Universal Clinical Codes & Terminology Search

Reposition Thoracic Aorta Ascending/Arch Open Approach

Destruction/reduction of malignant breast tumor with externally applied focused microwave including interstitial placement of disposable catheter with combined temperature monitoring probe and microwave focusing sensocatheter under ultrasound thermotherapy guidance

Arthrodesis pre-sacral interbody technique including disc space preparation discectomy with posterior instrumentation with image guidance includes bone graft when performed lumbar L4-L5 interspace (List separately in addition to code for primary procedure)

Vagus nerve blocking therapy (morbid obesity); laparoscopic implantation of neurostimulator electrode array anterior and posterior vagal trunks adjacent to esophagogastric junction (EGJ) with implantation of pulse generator includes programming

Oncology (pancreas) DNA and mRNA next-generation sequencing analysis of 74 genes and analysis of CEA (CEACAM5) gene expression pancreatic cyst fluid algorithm reported as a categorical result (ie negative low probability of neoplasia or positive high probability of neoplasia)

Nephrology (renal transplant) RNA expression by select transcriptome sequencing using posttransplant peripheral blood algorithm reported as a risk score for acute cellular rejection

Neurology (autism spectrum disorder [ASD]) quantitative measurements of 14 acyl carnitines and microbiome-derived metabolites liquid chromatography with tandem mass spectrometry (LC-MS/MS) plasma results reported as negative or positive for risk of metabolic subtypes associated with ASD

Repositioning of subcutaneous implantable defibrillator electrode and/or pulse generator

Oncology (pancreatic cancer) multiplex immunoassay of C5 C4 cystatin C factor B osteoprotegerin (OPG) gelsolin IGFBP3 CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9 serum diagnostic algorithm reported qualitatively as positive negative or borderline

Bioelectrical impedance analysis whole body composition assessment with interpretation and report

Neurology (mild cognitive impairment) analysis of B-amyloid 1-42 and 1-40 chemiluminescence enzyme immunoassay cerebral spinal fluid reported as positive likely positive or negative

Exposure behavioral follow-up assessment includes physician or other qualified health care professional direction with interpretation and report administered by physician or other qualified health care professional with the assistance of one or more technicians; first 30 minutes of technician(s) time face-to-face with the patient

APAP 120 MG Rectal Suppository

Exposure behavioral follow-up assessment includes physician or other qualified health care professional direction with interpretation and report administered by physician or other qualified health care professional with the assistance of one or more technicians; each additional 30 minutes of technician(s) time face-to-face with the patient (List separately in addition to code for primary procedure)

Exposure adaptive behavior treatment with protocol modification requiring two or more technicians for severe maladaptive behavior(s); first 60 minutes of technicians' time face-to-face with patient

Exposure adaptive behavior treatment with protocol modification requiring two or more technicians for severe maladaptive behavior(s); each additional 30 minutes of technicians' time face-to-face with patient (List separately in addition to code for primary procedure)

External heart rate and 3-axis accelerometer data recording up to 14 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; includes report scanning analysis with report review and interpretation by a physician or other qualified health care professional

External heart rate and 3-axis accelerometer data recording up to 14 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only

External heart rate and 3-axis accelerometer data recording from 15 to 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; includes report scanning analysis with report review and interpretation by a physician or other qualified health care professional

External heart rate and 3-axis accelerometer data recording from 15 to 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only